SCHEMBL17016718

SCHEMBL17016718

CC(=O)CCC(=O)CCC(=O)CCCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.62
▸ SLC15A2 Q16348 1/20 0.62
▸ SLC22A6 Q4U2R8 2/20 0.55
▸ KMT2A Q03164 2/20 0.54
▸ MAPT P10636 1/20 0.54
▸ KDM4E B2RXH2 1/20 0.52
▸ KDM6B O15054 1/20 0.52
▸ KDM5C P41229 1/20 0.52
▸ EGLN1 Q9GZT9 1/20 0.52
▸ PHF8 Q9UPP1 1/20 0.52
▸ KDM2A Q9Y2K7 1/20 0.52
▸ FNTA P49354 2/20 0.50
▸ FNTB P49356 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ ACE P12821 1/20 0.48
▸ TSHR P16473 4/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ PMP22 Q01453 1/20 0.46
▸ AKR1B1 P15121 1/20 0.44
▸ FOLH1 Q04609 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28208269 1.00 LMNA (0.62) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL13894505 1.00 LMNA (0.62) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL2730065 0.95 LMNA (0.62) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL11869641 0.92 SLC22A6 (0.58) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL11683116 0.89 ALDH1A1 (0.62) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL28505622 0.87 LMNA (0.82) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL21174517 0.87 LMNA (0.82) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL26625806 0.87 LMNA (0.82) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL27441461 0.87 ALDH1A1 (0.59) LMNASLC15A2SLC22A6KMT2AMAPT
SCHEMBL10600091 0.87 SLC22A6 (0.73) LMNASLC22A6KMT2AMAPTEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9422207-B2 Compounds and methods for the production of long chain hydrocarbons from biological sources LOS ALAMOS NATIONAL SECURITY, LLC (US) 2016-08-23 — — US disclosed
US-9422207-B2 Compounds and methods for the production of long chain hydrocarbons from biological sources LOS ALAMOS NATIONAL SECURITY, LLC (US) 2016-08-23 — — US disclosed
US-20150232394-A1 COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-08-20 — — US disclosed
US-20150232394-A1 COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232394-A1 COMPOUNDS AND METHODS FOR THE PRODUCTION OF LONG CHAIN HYDROCARBONS FROM BIOLOGICAL SOURCES HSD17B12, AKR1C4, FASN LMNA 891/4885SLC15A2 4398/4885SLC22A6 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback